Linkedin-in

AvenCell shared preclinical data of our allogeneic platform at AACR 2023

20230418_113503

AvenCell presented pre-clinical data on its CD123-directed allogeneic CAR T cell therapy at the American Association of Cancer Research Annual Meeting on April 18, 2023. The data showcases AVC-201, the first program that integrates AvenCell’s two proprietary platforms: Universal Switchable CAR and Allogeneic Cells, to create a potent and safe off-the-shelf CAR therapy that can be quickly activated and switched off. AVC-201 will soon be explored in the clinical setting for acute myeloid leukemia (AML).

Preclinical characterization of switchable allogeneic chimeric antigen receptor T cells to support first in human clinical study in CD123-positive hematologic and lymphatic malignancies

 

Share This Post

Avencell HighRes white
  • Contact
  • Email
  • HQ

Contact Us!

©2023 AvenCell Therapeutics, Inc. All Rights Reserved.

Linkedin

Biotech website design

icon dev

Susan Buttler

VP, Clinical Operations

Susan is the Vice President, Clinical Operations for Avencell; she brings over 30 years of experience in Global Clinical Operations to AvenCell’s Clinical Operations team.  Prior to joining Avencell, Susan had multiple senior level roles within the Biotech, Pharmaceutical and CRO organizations.  Susan has experience in leading clinical operations teams to successful study execution and multiple global regulatory submissions. Susan is a graduate of the University of Wisconsin-Milwaukee with a Bachelor of Science in Medical Technology.

Andrew Schiermeier, Ph.D.

Chief Executive Officer

Want to discuss my work or a challenge you’re facing?  Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing?  Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing?  Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing?  Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing?  Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing?  Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing?  Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing?  Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing?  Leave your details and I’ll get back to you.

Want to discuss my work or a challenge you’re facing?  Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing?  Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing?  Leave your details and I’ll get back to you.